Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation

Abstract

In a prospective randomized trial preemptive valganciclovir therapy and valacyclovir prophylaxis were equally effective in the prevention of CMV disease after renal transplantation.

Keywords

• cytomegalovirus